In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Building Medtronic Neuro by Trial: An Interview with Richard Kuntz, MD

Executive Summary

Medtronic is the acknowledged leader in one of the hottest device sectors-neurostimulation-but even this giant struggles with problems of limited market penetration. So Medtronic is bringing a new approach to this area: an aggressive clinical trials strategy to differentiate its products and drive physician adoption. Who better to run the business than a clinical trials expert? Richard Kuntz talks about future neuro opportunities and the current challenges facing device clinical trials.

Related Content

Medtronic: Doing Just What the Doctors Order
Seizure Desist: Neurostim Companies Pursue Alternative Treatments for Epilepsy
US Markets for Neurostimulation Products
TCT Highlights: Late Stent Thrombosis Controversy Continues
Neurostimulation's Billion-Dollar Markets
Stimulating Growth: St. Jude buys ANS
Northstar's Buzz
Cyberonics Stumbles and ANS Lends a Hand
Convergent Calling: An Interview with Medtronic's Stephen Oesterle
ANS Goes Along For The Ride


Related Companies

Related Deals




Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts